In order to clarify the extent of complement involvement in human cases of tauopathies across the various subtypes, we investigated complement proteins, regulators, and activation products in post‐mortem brains obtained from tauopathy patients with either CBD, GGT, or PiD. The gene discussed is VTN; the disease is tauopathy.